文献速递关节外科

全膝关节置换术后实质性临床获益阈值设定过高:基于美国关节置换登记处的分析

Substantial Clinical Benefit After Total Knee Arthroplasty Has Been Set Too High: An Analysis of the American Joint Replacement Registry.
PubMed 文献 · J Bone Joint Surg Am · 2026-01-29

该研究基于美国关节置换登记处2018至2023年1,284,404例初次全膝关节置换术病例,分析64,773例有链接评分患者术后1年KOOS-JR的MCID和SCB达标率。结果显示分布法MCID达标率86.8%、锚定法MCID达标率76.5%、SCB(20分)达标率65.7%。作者认为CMS设定的SCB阈值过高。

要点

  • 术后1年KOOS-JR的SCB(20分)达标率为65.7%。
  • 分布法MCID(7.5)达标率86.8%,锚定法MCID(14)达标率76.5%。
  • 术前评分较高、亚洲、黑人、西班牙裔及其他种族、男性、BMI较高者SCB达标几率更低。

核心结论

  • CMS相对任意地将SCB设定在一个对于常规患者满意度超过80%的手术而言过高的值。

研究设计与样本

  • 查询美国关节置换登记处(AJRR),筛选2018至2023年施行的1,284,404例初次全膝关节置换术病例。
  • 采用广义线性模型(二分类结局)评估协变量与MCID及SCB达标之间的关联,并考虑机构内聚类效应。
  • 报告未调整和调整后的比值比(OR)及其95%置信区间(CI)。

主要发现

  • 共有64,773例患者记录了链接评分,平均年龄68.35±8.60岁,女性占61.29%,非西班牙裔白人占83.52%。
  • KOOS-JR阈值达标率:计算得出的分布法MCID为86.8%,锚定法MCID为76.5%,SCB为65.7%。
  • 术前评分较高者SCB达标几率更低(调整OR 0.93 [95%CI 0.93至0.93],p<0.001)。
  • 亚洲患者(调整OR 0.59 [95%CI 0.46至0.74],p<0.001)、黑人患者(调整OR 0.55 [95%CI 0.49至0.62],p<0.001)、西班牙裔患者(调整OR 0.71 [95%CI 0.51至0.99],p=0.042)、其他种族非西班牙裔患者(调整OR 0.84 [95%CI 0.74至0.95],p=0.007)、男性患者(调整OR 0.89 [95%CI 0.85至0.94],p<0.001)及BMI较高者(调整OR 0.93 [95%CI 0.87至0.99],p=0.025)SCB达标几率更低。
  • CCI≥5与分布法MCID达标几率更低相关(调整OR 0.89 [95%CI 0.79至0.99],p=0.032),也与锚定法MCID达标几率更低相关(调整OR 0.89 [95%CI 0.81至0.97],p=0.012)。

关键数值与推荐

  • CMS将初次全膝关节置换术后KOOS-JR的SCB设定为20分。
  • 分布法MCID为7.5,锚定法MCID为14,SCB为20,均在术后12个月评估。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The U.S. Centers for Medicare & Medicaid Services (CMS) has set the substantial clinical benefit (SCB) for the Knee injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS-JR) after primary total knee arthroplasty (TKA) at 20 points. We aimed to determine the percentages of patients who achieved the minimal clinically important difference (MCID) and the SCB for KOOS-JR at 1 year following TKA and to evaluate factors associated with benchmark achievement. METHODS: We queried the American Joint Replacement Registry (AJRR) and screened 1,284,404 primary TKA cases performed from 2018 to 2023. We determined attainment of the KOOS-JR distribution-based MCID (7.5), anchor-based MCID (14), and SCB (20) at 12 months by each patient. Associations of covariates with the achievement of the MCIDs and the SCB were evaluated using a generalized linear model for binary outcomes that accounted for clustering within institutions. Unadjusted and adjusted odds ratios (ORs) for the outcomes of interest with 95% confidence intervals (CIs) were reported. Covariates included the preoperative KOOS-JR, sex, race or ethnicity, body mass index (BMI), Charlson Comorbidity Index (CCI), fixation type, use of technology, year of the procedure, region, institution type, teaching status, and number of beds. RESULTS: Linked scores were recorded by 64,773 patients. The mean patient age was 68.35 ± 8.60 years, 61.29% of patients were female, and 83.52% of patients were non-Hispanic White. The KOOS-JR threshold achievement rate was 86.8% for the calculated distribution-based MCID, 76.5% for the anchor-based MCID, and 65.7% for the SCB. Patients with higher preoperative scores (adjusted OR, 0.93 [95% CI, 0.93 to 0.93]; p < 0.001), Asian patients (adjusted OR, 0.59 [95% CI, 0.46 to 0.74]; p < 0.001), Black patients (adjusted OR, 0.55 [95% CI, 0.49 to 0.62]; p < 0.001), Hispanic patients (adjusted OR, 0.71 [95% CI, 0.51 to 0.99]; p = 0.042), non-Hispanic patients of other races (adjusted OR, 0.84 [95% CI, 0.74 to 0.95]; p = 0.007), male patients (adjusted OR, 0.89 [95% CI, 0.85 to 0.94]; p < 0.001), and patients with higher BMI (adjusted OR, 0.93 [95% CI, 0.87 to 0.99]; p = 0.025) showed lower odds of achieving the SCB. A CCI of ≥5 was additionally found to be associated with lower odds of achieving the distribution-based MCID (adjusted OR, 0.89 [95% CI, 0.79 to 0.99]; p = 0.032) and anchor-based MCID (adjusted OR, 0.89 [95% CI, 0.81 to 0.97]; p = 0.012). CONCLUSIONS: The CMS relatively arbitrarily defined the SCB at a value that is too high for an operation that routinely yields >80% patient satisfaction. LEVEL OF EVIDENCE: Prognostic Level II . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Zalikha L, Chen KL, Pius AK, et al. Substantial Clinical Benefit After Total Knee Arthroplasty Has Been Set Too High: An Analysis of the American Joint Replacement Registry. J Bone Joint Surg Am. 2026. PMID: 41610198. doi:10.2106/JBJS.25.00952

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。